Alexander O. Schuth Denali Therapeutics Inc. (DNLI) insider trading activity

Alexander O. Schuth is COFO and Secretary of Denali Therapeutics Inc.. Currently has a direct ownership of 242,346 shares of DNLI, which is worth approximately $4.23 Million. The most recent transaction as insider was on Aug 12, 2025, when has been sold 2,937 shares (Common Stock) at a price of $13.58 per share, resulting in proceeds of $39,884. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 242K

0% 3M change

22.04% 12M change

Total Value Held $4.23 Million

Alexander O. Schuth Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 12 2025	SELL Open market or private sale	$39,884 $13.58 p/Share	2,937 Reduced 1.2%	242,346 Common Stock
Jan 07 2025	SELL Open market or private sale	$60,494 $20.81 p/Share	2,907 Reduced 1.18%	244,308 Common Stock
Jan 06 2025	SELL Open market or private sale	$247,796 $20.22 p/Share	12,255 Reduced 4.72%	247,215 Common Stock
Jan 03 2025	BUY Grant, award, or other acquisition	-	54,180 Added 17.27%	259,470 Common Stock
Dec 27 2024	BUY Exercise of conversion of derivative security	$35,418 $5.28 p/Share	6,708 Added 3.16%	205,290 Common Stock
Nov 22 2024	BUY Exercise of conversion of derivative security	$13,950 $0.68 p/Share	20,516 Added 9.36%	198,582 Common Stock
Nov 07 2024	SELL Open market or private sale	$475,452 $30.56 p/Share	15,558 Reduced 8.04%	178,066 Common Stock

Nov 07 2024	BUY Exercise of conversion of derivative security	$82,146 $5.28 p/Share	15,558 Added 7.44%	193,624 Common Stock
Aug 21 2024	SELL Open market or private sale	$63,114 $24.78 p/Share	2,547 Reduced 1.41%	178,066 Common Stock
Aug 20 2024	SELL Open market or private sale	$137,428 $23.67 p/Share	5,806 Reduced 3.11%	180,613 Common Stock
Aug 13 2024	SELL Open market or private sale	$52,006 $22.89 p/Share	2,272 Reduced 1.2%	186,419 Common Stock
Feb 14 2024	SELL Open market or private sale	$355,460 $17.66 p/Share	20,128 Reduced 9.7%	187,341 Common Stock
Feb 13 2024	SELL Open market or private sale	$46,959 $17.29 p/Share	2,716 Reduced 1.29%	207,469 Common Stock
Feb 08 2024	BUY Exercise of conversion of derivative security	$34,000 $0.68 p/Share	50,000 Added 19.22%	210,185 Common Stock
Jan 03 2024	BUY Grant, award, or other acquisition	-	53,720 Added 24.0%	170,157 Common Stock
Jan 04 2023	SELL Open market or private sale	$83,574 $28.7 p/Share	2,912 Reduced 1.91%	149,828 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	41,120 Added 20.69%	157,578 Common Stock
Aug 09 2022	BUY Grant, award, or other acquisition	-	22,500 Added 15.63%	121,458 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	31,000 Added 20.88%	117,454 Common Stock
Sep 20 2021	BUY Exercise of conversion of derivative security	$6,151 $0.68 p/Share	9,045 Added 8.65%	95,499 Common Stock

AOS

Alexander O. Schuth

COFO and Secretary

South San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNLI shares.

Notify only if

Value

Insider Trading

Get notified when an Denali Therapeutics Inc. insider buys or sells DNLI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Denali Therapeutics Inc.

Track Activities on DNLI

Account